期刊文献+

联合药物治疗老年2型糖尿病患者临床疗效研究 被引量:3

下载PDF
导出
摘要 目的:评价吡格列酮联合胰岛素治疗老年糖尿病患者的临床疗效。方法:选取在本科住院的2型老年糖尿病患者共100例,随机平均分为两组,即对照组和观察组,每组50例。两组患者在干预前均给予糖尿病基础治疗,观察组给予胰岛素+吡格列酮联合治疗。结果:本研究选取的FBG、2hPG、HbAlc指标值两组患者与治疗前比较均明显下降(P<0.05),观察组患者下降更明显,与对照组患者比较,差异有统计学意义(P<0.05)。胰岛素用量上,观察组和对照组比较差异也有统计学意义(P<0.05)。结论:应用胰岛素与吡格列酮联合药物治疗2型糖尿病,不但可以很好地控制患者的血糖、血脂值,而且患者依从性好,具有重要的临床应用价值。
作者 毛伟光
出处 《中国当代医药》 2011年第7期169-170,共2页 China Modern Medicine
  • 引文网络
  • 相关文献

参考文献4

二级参考文献14

  • 1Christian W,Antonio T,Clifton B,et al.Insulin resistance and insulin secretary dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development.Diabetes Care,2001,24( 1 ):89-94.
  • 2Amoah A G,Owusu S K,Schuster D P,et al.Pathogenic mechanism of type 2 diabetes in Chanaians-the importance of beta cell secretion,insulin sensitivity and glucose effective-ness.Afr Med,2002,92 ( 5 ):377-384.
  • 3Harmon JS,Gleason CE,Tanaka Y,et al.In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression.Diabetes,1999,48 (10):1995.
  • 4Shimabukuro M,Zhou YT,Levi M,et al.Fatty acid-induced βcell apoptosis:a link between obesity and diabetes.Proc Natl Acad Sci USA,1998,95(5 ):2498-2502.
  • 5Porter L E,Freed M I,Jones N P,et al.Rosiglitazone improves β-cell function as measured by proinsulin/insulin ratio in patients with type 2 diabetes[].Diabetes.2000
  • 6Rubin C,Egan J,Schneider R.Combination therapy with pioglitazone and insulin in patients with type 2 diabetes[].Diabetes.1999
  • 7Miyazaki Y,Mahankali A,Matsuda M,et al.Effect of Pioglitazone on abdominal fat distribution and insulin sensitivity in patients with type 2 diabetes mellitus[].Diabetes.2000
  • 8Spiegelman BM.PPARγadipogenic regulator and thiozolidinedione receptor[].Diabetes.1998
  • 9Barman-Balfour JA,Plosker GL.Rosiglitazone[].Drugs.1999
  • 10Lebovitz HE,Salzman A.Rosiglitazone liver safety update[].Diabetes.2000

共引文献113

同被引文献12

引证文献3

二级引证文献4

;
使用帮助 返回顶部